Showing results (751-760 of 853) with videos related to

Sort By:
Pageof 86
Scientific Reports|February 9, 2020
Microtubules as Sub-Cellular MemristorsJack A Tuszynski, Douglas Friesen, Holly Freedman, et al.
Cancer Chemotherapy and Pharmacology|January 5, 2021
Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1-XPF-mediated DNA repairGloria Ciniero, Ahmed H Elmenoufy, Francesco Gentile, et al.
Cancer Research|July 15, 2022
The Mechanisms of Action of Tumor Treating FieldsJustin C Moser, Ellaine Salvador, Karina Deniz, et al.
Circulation Research|April 7, 2007
Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesisIzabela Staniszewska, Shachi Zaveri, Luis Del Valle, et al.
Fundamental & Clinical Pharmacology|November 9, 2024
The synergy between alkylating agents and ERCC1-XPF inhibitors is p53 dependentGloria Ciniero, Tiago Marques Pedro, Charles Dumontet, et al.
Experimental Brain Research|December 21, 2010
Unconstrained three-dimensional reaching in rhesus monkeysDevin L Jindrich, Gregoire Courtine, James J Liu, et al.
Nature Nanotechnology|December 20, 2016
Real-time shape approximation and fingerprinting of single proteins using a nanoporeErik C Yusko, Brandon R Bruhn, Olivia M Eggenberger, et al.
Plos One|June 9, 2015
Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer CellsMarc St George, Ahmed T Ayoub, Asok Banerjee, et al.
Annals of Neurology|January 1, 1997
Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factorJ Winkler, G A Ramirez, H G Kuhn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Clinical significance of thrombospondin 1 expression in hepatocellular carcinomaRonnie T Poon, Ka Kit Chung, Siu Tim Cheung, et al.
Pageof 86